1. Home
  2. MOGO vs PMN Comparison

MOGO vs PMN Comparison

Compare MOGO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • PMN
  • Stock Information
  • Founded
  • MOGO 2003
  • PMN 2004
  • Country
  • MOGO Canada
  • PMN Canada
  • Employees
  • MOGO N/A
  • PMN N/A
  • Industry
  • MOGO
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • MOGO
  • PMN Health Care
  • Exchange
  • MOGO Nasdaq
  • PMN Nasdaq
  • Market Cap
  • MOGO 42.5M
  • PMN 22.3M
  • IPO Year
  • MOGO N/A
  • PMN N/A
  • Fundamental
  • Price
  • MOGO $1.86
  • PMN $0.46
  • Analyst Decision
  • MOGO Strong Buy
  • PMN Strong Buy
  • Analyst Count
  • MOGO 1
  • PMN 3
  • Target Price
  • MOGO $4.00
  • PMN $4.33
  • AVG Volume (30 Days)
  • MOGO 255.0K
  • PMN 3.1M
  • Earning Date
  • MOGO 11-05-2025
  • PMN 11-13-2025
  • Dividend Yield
  • MOGO N/A
  • PMN N/A
  • EPS Growth
  • MOGO N/A
  • PMN N/A
  • EPS
  • MOGO 0.12
  • PMN N/A
  • Revenue
  • MOGO $30,265,570.00
  • PMN N/A
  • Revenue This Year
  • MOGO $61.97
  • PMN N/A
  • Revenue Next Year
  • MOGO $4.03
  • PMN N/A
  • P/E Ratio
  • MOGO $15.97
  • PMN N/A
  • Revenue Growth
  • MOGO 0.18
  • PMN N/A
  • 52 Week Low
  • MOGO $0.74
  • PMN $0.38
  • 52 Week High
  • MOGO $3.83
  • PMN $1.59
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 54.71
  • PMN 43.27
  • Support Level
  • MOGO $1.78
  • PMN $0.39
  • Resistance Level
  • MOGO $1.92
  • PMN $0.45
  • Average True Range (ATR)
  • MOGO 0.08
  • PMN 0.04
  • MACD
  • MOGO 0.00
  • PMN 0.00
  • Stochastic Oscillator
  • MOGO 70.00
  • PMN 38.24

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: